Choosing adjunctive glaucoma therapy

Jess T. Whitson

doi:10.1007/978-0-387-76700-0_52

Choosing adjunctive glaucoma therapy

Jess T. Whitson

Research output: Chapter in Book/Report/Conference proceeding › Chapter

3 Scopus citations

Abstract

Glaucoma is a group of optic neuropathies characterized by retinal ganglion cell death, irreversible optic nerve damage, and vision loss. The treatment of glaucoma consists of reducing intraocular pressure (IOP) to a target level that is presumed to prevent further optic nerve deterioration. This presumption of clinical stability should be reevaluated at each clinical encounter with the patient and a new lower target IOP level estimated if progression has occurred.

Original language	English (US)
Title of host publication	The Glaucoma Book
Subtitle of host publication	A Practical, Evidence-Based Approach to Patient Care
Publisher	Springer New York
Pages	629-641
Number of pages	13
ISBN (Print)	9780387766997
DOIs	https://doi.org/10.1007/978-0-387-76700-0_52
State	Published - Jan 1 2010

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1007/978-0-387-76700-0_52

Cite this

@inbook{17e2fd06164f41c180ffef06068e5751,

title = "Choosing adjunctive glaucoma therapy",

abstract = "Glaucoma is a group of optic neuropathies characterized by retinal ganglion cell death, irreversible optic nerve damage, and vision loss. The treatment of glaucoma consists of reducing intraocular pressure (IOP) to a target level that is presumed to prevent further optic nerve deterioration. This presumption of clinical stability should be reevaluated at each clinical encounter with the patient and a new lower target IOP level estimated if progression has occurred.",

author = "Whitson, {Jess T.}",

year = "2010",

month = jan,

day = "1",

doi = "10.1007/978-0-387-76700-0_52",

language = "English (US)",

isbn = "9780387766997",

pages = "629--641",

booktitle = "The Glaucoma Book",

publisher = "Springer New York",

}

TY - CHAP

T1 - Choosing adjunctive glaucoma therapy

AU - Whitson, Jess T.

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Glaucoma is a group of optic neuropathies characterized by retinal ganglion cell death, irreversible optic nerve damage, and vision loss. The treatment of glaucoma consists of reducing intraocular pressure (IOP) to a target level that is presumed to prevent further optic nerve deterioration. This presumption of clinical stability should be reevaluated at each clinical encounter with the patient and a new lower target IOP level estimated if progression has occurred.

AB - Glaucoma is a group of optic neuropathies characterized by retinal ganglion cell death, irreversible optic nerve damage, and vision loss. The treatment of glaucoma consists of reducing intraocular pressure (IOP) to a target level that is presumed to prevent further optic nerve deterioration. This presumption of clinical stability should be reevaluated at each clinical encounter with the patient and a new lower target IOP level estimated if progression has occurred.

UR - http://www.scopus.com/inward/record.url?scp=84892251671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892251671&partnerID=8YFLogxK

U2 - 10.1007/978-0-387-76700-0_52

DO - 10.1007/978-0-387-76700-0_52

M3 - Chapter

AN - SCOPUS:84892251671

SN - 9780387766997

SP - 629

EP - 641

BT - The Glaucoma Book

PB - Springer New York

ER -

Choosing adjunctive glaucoma therapy

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this